Organ Targeted Therapy

Accurately remove tumors from targeted organs

On the basis of targeted decapitation of tumor lesions using sustained-release depot therapy, Professor Yu Baofa has developed various organ targeted drug carriers for chemotherapy and has obtained a US patent. It can work together with slow-release library therapy to remove residual small lesions or small tumors that cannot be treated by slow-release library therapy, specifically for lymph node cancer, bone metastasis cancer, liver cancer, and brain cancer.